Call for abstracts for International Session in the JSPRS2024 Annual Meeting opens on
Monday, October 2, 2023, noon (JST, UTC+9) until Monday, October 30, 2023, noon (JST, UTC+9)

Important Dates

Deadline for Abstract Submission	October 30, 2023, noon (JST, UTC+9)
Notification of Acceptance (by E-mail)	Email will be sent in the beginning of February
Deadline for Registration	February 13, 2024 (JST, UTC+9)

• ・Abstracts should be submitted online.
• ・All abstract applicants are required to create a user account first.
• ・Once the submission is completed, a confirmation e-mail will be sent automatically. If you do not receive the confirmation e-mail within 24 hours after submission, please contact the Congress Secretariat (E-mail: jsprs67@jtbcom.co.jp).
• ・Abstract number will be generated automatically when an abstract is submitted.
• ・For changes, withdrawal or additional submission, please log in to the system using your ID and password from "Abstract Submission" button at the bottom of this page.

• ・All authors submitting an abstract must register for the Annual Meeting by February 13 (Tue.), 2024.
• ・The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract.
• ・The presenting author must be one of the co-authors listed on the submitted abstract.
• ・The presenting author is responsible for ensuring that all authors have read the abstract and agreed to be co-authors.

Each speaker will have 10 minutes for presentation. Please time your talk for 8 minutes, and 2 minutes for questions and answers.
*Type of presentation in the JSPRS2024 is only ORAL PRESENTATION.

Your abstract must include:

• ・Your Name (Name of the First Author)
• ・Name(s) of Affiliation (This will be printed in the Program Book)
• ・Name(s) and Affiliation(s) for Co-Authors (up to 8 people)
• ・Contact E-mail Address
• ・Title of Abstract (within 15 words)
  The abstract title should be brief and clearly indicate the nature of the presentation. Do not put a period at the end of the title.
• ・Abstract Body (within 250 words)
  The entire body of the abstract must not exceed 250 words.
  Spaces are not included in this number. No tables or diagrams should be included.
• ・Category
  Please select 1 or 2 Categories to your abstract. (Categories will not be printed in the Program Book; they will be used as a reference for peer review.)

Category

01.	Aesthetic	13.	Head & Neck Reconstruction
02.	Aesthetic Breast Surgery	14.	Microsurgery / Supermicrosurgery
03.	Benign and Malignant Tumors	15.	Migraine Surgery
04.	Blepharoplasty	16.	Laser
05.	Breast Reconstruction	17.	Liposuction / Body Contouring
06.	Burn	18.	Lymphedema / Lymphatic Surgery
07.	Cell-Based Therapy	19.	Otoplasty
08.	Chronic Wound	20.	Regenerative Medicine
09.	Cranio- / Maxillofacial Surgery	21.	Robotic Surgery
10.	Fat grafting	22.	Scar / Hypertrophic Scar/Keroid
11.	Gender Confirmation Medicine/Surgery, Sex Reassignment Surgery	23.	Wound Healing
12.	Hand	24.	Miscellaneous

• ・After the submission deadline, all completed and eligible abstracts will be made available to the Organizing Review Committees for blinded review and scoring, and final decisions will be made in the end of January 2024.
• ・Incomplete abstracts will not be reviewed.
• ・All abstracts submitted will be considered eligible for one presentation (ORAL PRESENTATION).

• ・Notification regarding acceptance or rejection of abstracts will be sent to the first (presenting) author by the beginning of February 2024 by e-mail; consequently, an accurate e-mail address is critical. Rejection notifications will also be sent at that time.
• ・If you have not received the e-mail, please contact Congress Secretariat shown at the bottom of this page.

• ・Conflict-Of-Interest (COI) Policy requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict.
• ・Please disclose any relationships or circumstances that might affect or appear to affect the research presented. These relationships include you or any individual with whom you directly share income.
• ・All authors and co-authors are required to provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the presentation; including relationships with pharmaceutical companies, or other companies whose products or services are related to the subject matter of the presentation topic. If no relevant relationships exist, this must be stated as well.

Abstract Submission

CONGRESS SECRETARIAT
c/o JTB Communication Design, Inc.
8F, JTB Building, 2-1-25 Kyutaro-machi, Chuo-ku, Osaka 541-0056, Japan
TEL: +81-6-4964-8869　FAX: +81-6-4964-8804　E-mail: jsprs67@jtbcom.co.jp